CALGARY, AB and SAN FRANCISCO – April 20, 2022 – Thoma Bravo, a leading software investment firm, today announced the completion of its strategic growth investment in Circle Cardiovascular Imaging Inc. ("Circle CVI"), the global leader in cardiovascular imaging solutions.
Read Full ArticleCALGARY, AB and SAN FRANCISCO, March 16, 2022 -- Circle Cardiovascular Imaging Inc. ("Circle CVI"), the global leader in cardiovascular imaging solutions, today announced a strategic growth investment from Thoma Bravo, a leading software investment firm. Thoma Bravo's partnership is expected to drive future investment in product innovation, extend Circle CVI's market leadership position and fuel future growth. Financial terms of the transaction were not disclosed.
Read Full ArticleCalgary, Canada, and Be’er Sheva, Israel, June 14, 2021 – Today, Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. are excited to announce a multi-year partnership that leverages the companies’ synergies in cardiac AI and data analytics.
Read Full ArticleCalgary, Alberta – Circle Neurovascular Imaging (Circle NVI), a majority owned subsidiary of Circle Cardiovascular Imaging (Circle CVI), in collaboration with members of the Calgary Stroke Program, is proud to announce obtainment of CE Mark for StrokeSENS™.
Read Full ArticleOrlando, FL – Today, at the 23rd SCMR Annual Scientific Sessions – Circle Cardiovascular Imaging Ltd. (“Circle”) and medneo GmbH (“medneo”) are excited to announce a new strategic global partnership offering a premiere “Magnetic Resonance (MR) as a service solution” dedicated for cardiovascular imaging. This cooperation will provide expanded patient access to state-of-the-art CMR whilst providing new opportunities for physicians, researchers, and hospitals globally.
Read Full ArticleChicago, IL - Today, at the 105th RSNA Scientific Assembly and Annual Meeting, IBM (NYSE: IBM) Watson Health™ (“Watson Health”) and Circle Cardiovascular Imaging (“Circle”) announced that cvi42, Circle’s AI-embedded single-platform solution for cardiovascular imaging reading and reporting, has been added to IBM Imaging AI Marketplace.
Read Full ArticleCalgary, Canada - As global leaders in cardiac imaging , Circle Cardiovascular Imaging Inc. (Circle) is proud to announce that cvi42 – its world class Cardiovascular Imaging reading and reporting solution – is being used in 9 of the 10 Ranked Best Hospitals in the World.
Read Full ArticleBellevue WA, USA - At the SCMR 2019 Meeting in Bellevue, Washington, which brings together top clinicians and researchers within the cardiovascular and MRI communities, Circle Cardiovascular Imaging Inc. (“Circle”), announced the acquisition of Corstem Inc. (“Corstem”) - a machine learning and artificial intelligence software developer specialized in cardiac imaging analysis. As current global leaders in Cardiac MRI reading and reporting solutions, this acquisition will further expand Circle’s innovative technology and product offerings. Corstem’s technologies will be integrated into Circle’s core product – cvi42 – and will include an automatic and comprehensive solution for fully-quantitative myocardial perfusion.
Read Full ArticleBellevue WA, USA – At the SCMR 2019 Meeting in Bellevue, Washington, which brings together top clinicians and researchers within the cardiovascular and MRI communities, Circle Cardiovascular Imaging Inc. (“Circle”), and Galgo Medical (“Galgo”), announced an agreement for distribution and joint development with respect to MRI scanner application products and workflows, with corresponding post-processing capabilities. The focus will be to improve cardiac magnetic resonance (MR) imaging workflows and diagnostic tools, to expand accessibility and use of Cardiac MR to electrophysiology procedures such as atrial fibrillation and ventricular tachycardia ablations. As current global leaders in Cardiac MRI reading and reporting solutions, this joint agreement will further expand Circle’s innovative technology and product offerings.
Read Full ArticleCalgary, AB - Circle Cardiovascular Imaging Inc. (“Circle”), a Calgary-based, global innovator in cardiovascular imaging (“CVI”) post-processing software, today announced an investment of $16M led by growth-stage private equity firms Kayne Anderson Capital Advisors (Los Angeles, California) and Yaletown Partners (Vancouver, British Columbia). Circle works with physicians and scientists, leading the way in diagnostic assessment and treatment planning for people with cardiovascular disease – a leading cause of death around the world, affecting more than 110 million people. The financing will enable Circle to accelerate its global commercialization of its advanced CVI software suite providing cardiologists and radiologists with the best quantitative tools for diagnosing a wide range of cardiovascular diseases.
Read Full Article